
ZURA
Zura Bio Ltd - Class A
$6.51
-1.44%Name
Zura Bio Ltd
Website
-
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Categories
CEO
-
Employees
7
Description
zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven by il7 and tslp biological pathways. zura bio aims to develop a portfolio of therapeutic indications for zb-168, and is focused on demonstrating its efficacy, safety, dosing convenience and mechanism of action, initially in alopecia areata. this will build on phase 1b data in type 1 diabetes demonstrating a favourable safety profile and strong biological rationale. zura bio is headquartered in london, uk with team members in the uk and usa.
Market Cap
$283.58M
52 Week High
$37.55
PE Ratio
-
52 Week Low
$4.87
EPS
-
Shares Outstanding
43.59M
Dividend Yield
-
Dividend Per Share
-
Name
Zura Bio Ltd
Website
-
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Categories
CEO
-
Employees
7
Description
zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven by il7 and tslp biological pathways. zura bio aims to develop a portfolio of therapeutic indications for zb-168, and is focused on demonstrating its efficacy, safety, dosing convenience and mechanism of action, initially in alopecia areata. this will build on phase 1b data in type 1 diabetes demonstrating a favourable safety profile and strong biological rationale. zura bio is headquartered in london, uk with team members in the uk and usa.